“My commitment is that if I am leader [of the US Senate], I am going to do everything I can to put the Marijuana Freedom and Opportunity Act on the floor of the Senate. The odds are very high it will pass.”
House lawmakers are preparing for a September floor vote on legislation – The Marijuana Opportunity, Reinvestment, and Expungement Act a/k/a The MORE Act — to remove marijuana from the federal Controlled Substances Act. The forthcoming vote would mark the first time since the passage of the Controlled Substances Act of 1970, which placed cannabis in the same category as heroin as a Schedule I controlled substance, that a Congressional chamber has voted to remove marijuana from its prohibitive classification.
Voters in several states will have the opportunity to decide at the ballot whether to legalize cannabis for either adult-use or for medical purposes. In addition, numerous local, state, and federal races involve candidates who have made marijuana legalization a key part of their platform.
Some opponents of marijuana policy reform have manipulated the Speaker’s comments to imply that she was opining that cannabis therapy has been proven specifically to be successful for the treatment of COVID-19.
Later this month, there will be a crucial vote in the US House of Representatives…
NORML leadership today sent an open letter to Nora D. Volkow, M.D., Director of the US National Institute on Drug Abuse (NIDA), asking her to recognize the detrimental impact that racially-discriminatory marijuana law enforcement has had on the public health of communities of color.
If you haven’t read our statement on the murder of George Floyd and the intersections…
Ten members of the Senate, led by Senators Jacky Rosen (D-NV) and Ron Wyden (D-OR), and 34 members of the House, led by Representatives Earl Blumenauer (D-OR) and Tom McClintock (R-CA), have recently issued letters requesting Small Business Administration funding programs be expanded so that they may be accessed by state-licensed cannabis businesses.